蓝芩口服液治疗放射性咽喉炎的疗效和安全性.docVIP

蓝芩口服液治疗放射性咽喉炎的疗效和安全性 目录 TOC \o 1-9 \h \z \u 目录 1 正文 1 文1：蓝芩口服液治疗放射性咽喉炎的疗效和安全性 1 1 对象和方法 2 2 结果 4 3 讨论 4 文2：喉炎宁口服液治疗急慢性咽喉炎的药效学研究 5 1 实验材料 6 2 方法与结果 6 3 讨论 9 参考文摘引言： 9 原创性声明（模板） 10 文章致谢（模板） 11 正文 蓝芩口服液治疗放射性咽喉炎的疗效和安全性 文1：蓝芩口服液治疗放射性咽喉炎的疗效和安全性 Abstract： Objective To observe the therapeutic effect of Lanqin oral solution on radiation laryngopharyngitis and its safety. Methods A total of 148 inpatients with malignant tumor were enrolled from the department of Traditional Chinese Medicine (TCM), PLA General Hospital. There were 81 males and 67 females aged from 31 to 87 yea. All the patients were diagnosed as malignant tumor by pathological or cytological examination, and were then diagnosed as radiation laryngopharyngitis after radiotherapy. Furthermore, they were divided into two groups at random, . trial group (n=100) and control group (n=48). The trial group were treated with Lanqin oral solution (10 ml, thrice per day), which was produced by Yangtze River Pharmacy Group Co. Ltd. The main cotituents were isatis root, scutellaria, gardenia, boatfruited sterculia, and cortex phellodendri. The control group was treated with heteropathy. Both the groups were treated for one week as a cycle of treatment. Results (1) The overall respoe rate of the trial group was higher than that of the control group (χ2=, χ2=, P). (2) The time, within which the clinical symptoms and sig disappeared, was shorter in the trial group than in the control group (P). Conclusion Lanqin oral solution is safe and effective on radiation laryngopharyngitis. It is worth spreading clinically. Key words： radiation laryngopharyngitis; lanqin oral solutio; clinical effect 放疗为许多发生于上半身的恶性肿瘤（如甲状腺癌、肺癌、食管癌、乳腺癌、鼻咽癌、腮腺癌、颈部淋巴结转移癌等）的主要治疗手段之一，在治疗过程中会不可避免地损伤正常组织和器官，引起各种放射性损伤，放射性咽喉炎即为其中之一。其症状酷似一般咽喉炎，但病情更复杂，病程缠绵，影响患者生活。作者采用蓝芩口服液治疗放射性咽喉炎，取得了比较满意的疗效。 1 对象和方法 对象 选择2005年6月—2007年6月解放军总 医院 中医科门诊及住院的恶性肿瘤患者148例，男81例，女67例，年龄31~87岁。纳入标准：（1）均为经病理或细胞学检查确诊的恶性肿瘤患者，需要接受放疗，无放疗禁忌证，机体状况Karnofsky≥70。（